Cargando…
Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
Theranostics is the integration of diagnostic information with pharmaceuticals to increase effectiveness and safety of cancer treatments. Nuclear medicine provides a non-invasive means to visualize drug target expression across primary and metastatic sites, and assess pharmacokinetics and efficacy o...
Autores principales: | Lau, Joseph, Lin, Kuo-Shyan, Bénard, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695016/ https://www.ncbi.nlm.nih.gov/pubmed/29158829 http://dx.doi.org/10.7150/thno.21848 |
Ejemplares similares
-
Design, synthesis and evaluation of (18)F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging
por: Zhang, Zhengxing, et al.
Publicado: (2017) -
New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents
por: Chen, Kuo-Ting, et al.
Publicado: (2022) -
Targeting Carbonic Anhydrase IX Activity and Expression
por: Mahon, Brian P., et al.
Publicado: (2015) -
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
por: McDonald, Paul C., et al.
Publicado: (2012) -
An update on anticancer drug development and delivery targeting carbonic anhydrase IX
por: Kazokaitė, Justina, et al.
Publicado: (2017)